Keymed Biosciences Inc., a biotech company focused on the urgent unmet clinical needs, announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational ...

LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...

The posters cover the Company’s new payload class, the ProAlk series, its CA242-directed ADC, IKS04, being developed for the treatment of gastrointestinal (GI) cancers, and its proprietary ...

Paclitaxel, ifosfamide, cisplatin (TIP) in patients with advanced urethral adenocarcinoma: A single center, retrospective analysis. Adjuvant nivolumab (NIVO) vs placebo (PBO) for high-risk ...

The ADC 104th Annual Awards, the world’s longest continuously running awards program celebrating design and craft excellence, has launched its call for entries alongside a striking new campaign ...

Elevation has identified the technologies as differentiators that could enable it to make a splash in the HER3 ADC market. The biotech will need its ADC to stand out given the head start it has ...

One year after a potential $1.7 billion deal with Hansoh Pharma, GSK goes back to China to forge another alliance with DualityBio for another deal that could be worth up to $1 billion as it continues ...

In the second setback for the HER3 field in days, the FDA has rejected Daiichi Sankyo’s Merck & Co.-partnered antibody-drug conjugate (ADC) patritumab deruxtecan. The drug, also known as HER3 ...

ADC also proposed to build a public plaza on the western end of the site, which is next to FORM Gallery Café, formerly the Goods Shed. The developer proposed to collaborate with DevelopmentWA to ...

Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, announced on May 30, 2024 that it has invested $3 million into expanding its integrated antibody-drug ...